 | • レポートコード：MRC309Z7194 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の鼻腔内薬剤&ワクチン送達デバイスの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の鼻腔内薬剤&ワクチン送達デバイス市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 鼻腔内薬剤&ワクチン送達デバイスの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 鼻腔内薬剤&ワクチン送達デバイス市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・粉体搬送装置、送液装置、加圧式定量吸入器、その他 用途別セグメント ・呼吸器疾患、神経系疾患、予防接種、疼痛科、その他 主要な市場プレーヤー ・Teva Pharmaceuticals、GlaxoSmithKline、Teleflex、Intersect、Aptar Pharma、3M、OptiNose、UCB、Bespak 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、鼻腔内薬剤&ワクチン送達デバイス製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な鼻腔内薬剤&ワクチン送達デバイスメーカーの企業概要、2019年～2022年までの鼻腔内薬剤&ワクチン送達デバイスの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な鼻腔内薬剤&ワクチン送達デバイスメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別鼻腔内薬剤&ワクチン送達デバイスの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの鼻腔内薬剤&ワクチン送達デバイスの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での鼻腔内薬剤&ワクチン送達デバイス市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および鼻腔内薬剤&ワクチン送達デバイスの産業チェーンを掲載しています。 ・第14、15章では、鼻腔内薬剤&ワクチン送達デバイスの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 鼻腔内薬剤&ワクチン送達デバイスの概要 - 種類別分析（2018年vs2022年vs2029年）：粉体搬送装置、送液装置、加圧式定量吸入器、その他 - 用途別分析（2018年vs2022年vs2029年）：呼吸器疾患、神経系疾患、予防接種、疼痛科、その他 - 世界の鼻腔内薬剤&ワクチン送達デバイス市場規模・予測 - 世界の鼻腔内薬剤&ワクチン送達デバイス生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Teva Pharmaceuticals、GlaxoSmithKline、Teleflex、Intersect、Aptar Pharma、3M、OptiNose、UCB、Bespak ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：粉体搬送装置、送液装置、加圧式定量吸入器、その他 ・用途別分析2018年-2029年：呼吸器疾患、神経系疾患、予防接種、疼痛科、その他 ・鼻腔内薬剤&ワクチン送達デバイスの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・鼻腔内薬剤&ワクチン送達デバイスのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・鼻腔内薬剤&ワクチン送達デバイスのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・鼻腔内薬剤&ワクチン送達デバイスの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・鼻腔内薬剤&ワクチン送達デバイスの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Intranasal Drug and Vaccine Delivery Devices market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Delivery devices for intranasal drugs and vaccines
This report is a detailed and comprehensive analysis for global Intranasal Drug and Vaccine Delivery Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Intranasal Drug and Vaccine Delivery Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intranasal Drug and Vaccine Delivery Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intranasal Drug and Vaccine Delivery Devices market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceuticals, GlaxoSmithKline, Teleflex, Intersect and Aptar Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Intranasal Drug and Vaccine Delivery Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Powder Conveyor
Liquid Delivery Device
Pressurized Metered Dose Inhaler
Other
Market segment by Application
Respiratory Diseases
Nervous System Disease
Vaccination
Pain Department
Other
Major players covered
Teva Pharmaceuticals
GlaxoSmithKline
Teleflex
Intersect
Aptar Pharma
3M
OptiNose
UCB
Bespak
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intranasal Drug and Vaccine Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intranasal Drug and Vaccine Delivery Devices, with price, sales, revenue and global market share of Intranasal Drug and Vaccine Delivery Devices from 2018 to 2023.
Chapter 3, the Intranasal Drug and Vaccine Delivery Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intranasal Drug and Vaccine Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Intranasal Drug and Vaccine Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intranasal Drug and Vaccine Delivery Devices.
Chapter 14 and 15, to describe Intranasal Drug and Vaccine Delivery Devices sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Intranasal Drug and Vaccine Delivery Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Powder Conveyor
1.3.3 Liquid Delivery Device
1.3.4 Pressurized Metered Dose Inhaler
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Respiratory Diseases
1.4.3 Nervous System Disease
1.4.4 Vaccination
1.4.5 Pain Department
1.4.6 Other
1.5 Global Intranasal Drug and Vaccine Delivery Devices Market Size & Forecast
1.5.1 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity (2018-2029)
1.5.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Teva Pharmaceuticals
2.1.1 Teva Pharmaceuticals Details
2.1.2 Teva Pharmaceuticals Major Business
2.1.3 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product and Services
2.1.4 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teva Pharmaceuticals Recent Developments/Updates
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product and Services
2.2.4 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GlaxoSmithKline Recent Developments/Updates
2.3 Teleflex
2.3.1 Teleflex Details
2.3.2 Teleflex Major Business
2.3.3 Teleflex Intranasal Drug and Vaccine Delivery Devices Product and Services
2.3.4 Teleflex Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teleflex Recent Developments/Updates
2.4 Intersect
2.4.1 Intersect Details
2.4.2 Intersect Major Business
2.4.3 Intersect Intranasal Drug and Vaccine Delivery Devices Product and Services
2.4.4 Intersect Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Intersect Recent Developments/Updates
2.5 Aptar Pharma
2.5.1 Aptar Pharma Details
2.5.2 Aptar Pharma Major Business
2.5.3 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product and Services
2.5.4 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Aptar Pharma Recent Developments/Updates
2.6 3M
2.6.1 3M Details
2.6.2 3M Major Business
2.6.3 3M Intranasal Drug and Vaccine Delivery Devices Product and Services
2.6.4 3M Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 3M Recent Developments/Updates
2.7 OptiNose
2.7.1 OptiNose Details
2.7.2 OptiNose Major Business
2.7.3 OptiNose Intranasal Drug and Vaccine Delivery Devices Product and Services
2.7.4 OptiNose Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 OptiNose Recent Developments/Updates
2.8 UCB
2.8.1 UCB Details
2.8.2 UCB Major Business
2.8.3 UCB Intranasal Drug and Vaccine Delivery Devices Product and Services
2.8.4 UCB Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 UCB Recent Developments/Updates
2.9 Bespak
2.9.1 Bespak Details
2.9.2 Bespak Major Business
2.9.3 Bespak Intranasal Drug and Vaccine Delivery Devices Product and Services
2.9.4 Bespak Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bespak Recent Developments/Updates
3 Competitive Environment: Intranasal Drug and Vaccine Delivery Devices by Manufacturer
3.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Manufacturer (2018-2023)
3.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Intranasal Drug and Vaccine Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Intranasal Drug and Vaccine Delivery Devices Manufacturer Market Share in 2022
3.4.2 Top 6 Intranasal Drug and Vaccine Delivery Devices Manufacturer Market Share in 2022
3.5 Intranasal Drug and Vaccine Delivery Devices Market: Overall Company Footprint Analysis
3.5.1 Intranasal Drug and Vaccine Delivery Devices Market: Region Footprint
3.5.2 Intranasal Drug and Vaccine Delivery Devices Market: Company Product Type Footprint
3.5.3 Intranasal Drug and Vaccine Delivery Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region
4.1.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Region (2018-2029)
4.1.2 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Region (2018-2029)
4.1.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Region (2018-2029)
4.2 North America Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018-2029)
4.3 Europe Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018-2029)
4.4 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018-2029)
4.5 South America Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018-2029)
4.6 Middle East and Africa Intranasal Drug and Vaccine Delivery Devices Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
5.2 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Type (2018-2029)
5.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
6.2 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Application (2018-2029)
6.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Application (2018-2029)
7 North America
7.1 North America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
7.2 North America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
7.3 North America Intranasal Drug and Vaccine Delivery Devices Market Size by Country
7.3.1 North America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2018-2029)
7.3.2 North America Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
8.2 Europe Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
8.3 Europe Intranasal Drug and Vaccine Delivery Devices Market Size by Country
8.3.1 Europe Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2018-2029)
8.3.2 Europe Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Market Size by Region
9.3.1 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
10.2 South America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
10.3 South America Intranasal Drug and Vaccine Delivery Devices Market Size by Country
10.3.1 South America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2018-2029)
10.3.2 South America Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Market Size by Country
11.3.1 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Intranasal Drug and Vaccine Delivery Devices Market Drivers
12.2 Intranasal Drug and Vaccine Delivery Devices Market Restraints
12.3 Intranasal Drug and Vaccine Delivery Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Intranasal Drug and Vaccine Delivery Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intranasal Drug and Vaccine Delivery Devices
13.3 Intranasal Drug and Vaccine Delivery Devices Production Process
13.4 Intranasal Drug and Vaccine Delivery Devices Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intranasal Drug and Vaccine Delivery Devices Typical Distributors
14.3 Intranasal Drug and Vaccine Delivery Devices Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer